Skip to main content

Table 2 Serum and urine concentrations of morphine, metabolites, and metabolic ratios (n = 24)

From: Serum and urine concentrations of morphine and morphine metabolites in patients with advanced cancer receiving continuous intravenous morphine: an observational study

 

Median

Mean

Range

Serum

Day1

 M (nmol/l)

268.8

5617.8

35.0–70302.6

 M6G (nmol/l)

216.7

613.6

21.7–5229.1

 M3G (nmol/l)

1036.6

2372.8

108.4–24160.2

 M6G/M (nmol/l)

0.6

1.6

0.0–9.3

 M3G/M (nmol/l)

3.1

5.0

0.1–21.5

Urine

Day1

 M (nmol/l)

33293.9

253924.0

1051.4–1380117.6

 M6G (nmol/l)

11485.3

31195.6

1267.3–268278.9

 M3G (nmol/l)

34780.8

81053.0

3828.9–518352.5

 M6G/M (nmol/l)

0.8

0.8

0.0–2.0

 M3G/M (nmol/l)

1.7

1.9

0.1–5.6

Day2

 M (nmol/l)

23130.5

407484.6

1401.8–3078804.8

 M6G (nmol/l)

10726.8

72322.2

1733.6–1177133.4

 M3G (nmol/l)

37272.8

227898.7

4664.5–4007047.2

 M6G/M (nmol/l)

0.8

0.7

0.0–1.3

 M3G/M (nmol/l)

1.7

1.7

0.1–4.0

Day3

 M (nmol/l)

19625.9

122126.5

350.5–2695750.3

 M6G (nmol/l)

12568.8

56816.3

650.1–686950.1

 M3G (nmol/l)

32938.8

460521.7

2600.4–1372594.1

 M6G/M (nmol/l)

0.6

0.9

0.0–4.7

 M3G/M (nmol/l)

2.0

2.6

0.1–15.2

  1. M Morphine, M6G Morphine-6-glucuronide, M3G Morphine-3-glucuronide